Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Published in: European Journal of Nuclear Medicine and Molecular Imaging 3/2012

01-03-2012 | Letter to the Editor

Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification

Authors: Alexander Kroiss, Daniel Putzer, Christian Uprimny, Clemens Decristoforo, Michael Gabriel, Wolfram Santner, Christof Kranewitter, Boris Warwitz, Dietmar Waitz, Dorota Kendler, Irene Johanna Virgolini

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 3/2012

Login to get access

Excerpt

Dear Sir, …
Literature
1.
Kroiss A, Putzer D, Uprimny C, Decristoforo C, Gabriel M, Santner W, et al. Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine. Eur J Nucl Med Mol Imaging. 2011;38:865–73. doi:10.​1007/​s00259-010-1720-x.PubMedCrossRef
Metadata
Title
Functional imaging in phaeochromocytoma and neuroblastoma with 68Ga-DOTA-Tyr3-octreotide positron emission tomography and 123I-metaiodobenzylguanidine: a clarification
Authors
Alexander Kroiss
Daniel Putzer
Christian Uprimny
Clemens Decristoforo
Michael Gabriel
Wolfram Santner
Christof Kranewitter
Boris Warwitz
Dietmar Waitz
Dorota Kendler
Irene Johanna Virgolini
Publication date
01-03-2012
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 3/2012
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-011-1962-2

Other articles of this Issue 3/2012

European Journal of Nuclear Medicine and Molecular Imaging 3/2012 Go to the issue

Original Article

Comparison of sequential planar 177Lu-DOTA-TATE dosimetry scans with 68Ga-DOTA-TATE PET/CT images in patients with metastasized neuroendocrine tumours undergoing peptide receptor radionuclide therapy

Original Article

The effects of 3-month atorvastatin therapy on arterial inflammation, calcification, abdominal adipose tissue and circulating biomarkers

Erratum

Erratum to: Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset

Letter to the Editor

Radiation dosimetry is a necessary ingredient for a perfectly mixed molecular radiotherapy cocktail

Letter to the Editor

Suggested pathway to assess radiation safety of 11C-labeled PET tracers for first-in-human studies

Original Article

18F-FDG PET/CT for detection and localization of residual or recurrent disease in patients with multiple myeloma after stem cell transplantation